get a key
steadybase-$ person Serge Seixonal
nameSerge Seixonal
roleCEO
company 10x Genomics Inc. TXG
linkedin none on file
contactnot published
filingsnone on file
quotes
So it's relatively subdued, and we're finding it's particularly subdued on the capital equipment side of things, where it's doing a fair bit of travel in Europe and in Asia, talking to customers. And yeah, there's just materially more scrutiny when it comes to instrument purchases, whereas in the past, you might have a PI just go ahead and buy an instrument, buy this sort of piece of equipment. Now the department comes over the top and asks them hard questions like, well, the instrument already exists at the uh you know another place in the institution like there's one at the core why don't you use that one for now instead of purchasing another one and so we're seeing that kind of pattern across the world just more pressure um now not universal obviously different geographies have all their own sort of pattern but i would say the high level uh the environment is somewhat subdued not nearly as bad as uh as what's in the us but also not sort of the high flying days of several years ago got it That's super helpful.

Nov 6, 2025 / CEO / receipt, needs a key / Serge Seixonal, CEO | earnings call 2025-11-06 | transcript 558624f9-d944-43da-ad0e-64c43b14a2a2 | chars 5087-6114 | segment 5

steadybase-$